Hershey's switching Reese's back to original recipe after backlash

Hershey announced at its March 31, 2026 Investor Day that products not aligned with original milk/dark chocolate and peanut butter recipes will be transitioned back by 2027. Only ~3% of Reese’s SKUs were reported to contain 'peanut butter crème' while core Reese’s Peanut Butter Cups remain on classic recipes, but public criticism from founder descendant Brad Reese and consumer taste complaints create reputational risk; management attributes earlier formulation shifts to changes after the CEO transition last August alongside inflation and higher cocoa costs that have pushed seasonal candy prices higher.

Analysis

This is primarily a brand-trust and margins story with a stretched remediation window — the operating mechanics are simple: sensory/ingredient changes create asymmetric downside in repurchase rates, while reversing those changes raises ingredient costs and forces margin reconciliation. Expect elevated volatility in unit volumes around seasonal events (next 1–3 quarters) as consumers re-test formulations; a persistent negative shift in repurchase probability of even a few percentage points would meaningfully widen marketing spend to regain share.

On the cost side, the decision to revert formulations is a mechanical increase in COGS that will not be absorbed immediately. If management maintains price, gross margins will compress until either pricing, mix, or productivity offsets are implemented; conversely, passing costs to consumers risks further churn. That tradeoff creates a multi-quarter margin/cash flow squeeze and raises the probability of revised guidance or incremental cost-savings announcements.

Secondary winners are nimble competitors and private-label entrants who can credibly claim “real peanut butter / milk chocolate” and exploit retailer merchandising windows; second-order supply impacts include temporary shifts in cocoa/peanut procurement volumes and co-manufacturer throughput as SKUs are reformulated. Regulatory and labeling scrutiny is now a live event risk that can accelerate transparency — and litigation or retailer contractual disputes are plausible catalysts.

Key near-term monitors: weekly POS and Nielsen/IRI volumes, social-sentiment spikes, gross-margin commentary in upcoming quarter, and any SKU recall/relabeling cadence. Expect market moves clustered around retail seasonal peaks (weeks) and quarterly reports (months); the full reputational unwind will play out over multiple quarters into a year-plus.

Key Decisions for Investors

• Short HSY via a 6–9 month put-spread to capture reputational downside while limiting capital at risk: buy 1x near‑the‑money 6–9m puts and sell 1x OTM puts to finance. Target asymmetry: 2:1 downside payoff if volumes miss by >2–3% on next two quarterly prints; trim on a sustainably positive uplift in weekly POS or guidance revision. Use a 10–15% adverse-move stop.
• Pair trade: short HSY / long MDLZ (equal notional) for 9–12 months to play share reallocation to competitors. Rationale: captures relative margin and premium-brand share shifts; hedge ratio sized to historical beta (~0.6 HSY:MDLZ) with profit if HSY underperforms by >5% over the timeframe.
• Small asymmetric long-option hedge: purchase a low-cost, longer-dated (12–18 month) HSY call (OTM) sized at 1–2% of portfolio to capture upside if brand remediation is well received or cocoa costs fall sharply. This preserves downside short exposure while limiting financing cost.
• Monitor retail and regulatory catalysts as trade triggers: set alerts on weekly Nielsen/IRI share swings, major social sentiment spikes, and any USDA/FTC inquiries; if both POS and sentiment normalize for two consecutive months, aggressively cut short exposure and redeploy into defensive staples with cleaner ingredient positioning.